Imbio signs Heart&Lung Health in U.K.
Artificial intelligence software developer Imbio has signed a deal with U.K...Read more on AuntMinnie.comRelated Reading: Imbio nets FDA nod for RV/LV Analysis AI algorithm Aidoc and Imbio team up on AI for pulmonary embolism Siemens adds Imbio AI apps to syngo.via platform Imbio teams up with Genentech for AI in lung disease Imbio adds analysis software to Nuance AI marketplace (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news

Radiology Partners joins forces with Aidoc
Imaging services provider Radiology Partners and artificial intelligence (AI...Read more on AuntMinnie.comRelated Reading: Radiology Partners promotes 13 radiologists Aidoc unveils AI notification application for PE Radiology Partners completes Mednax deal 3 predictions for radiology AI in 2021 Aidoc and Imbio team up on AI for pulmonary embolism Radiology Partners sees scale as benefit of Mednax deal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news

High thrombotic risk in cancer patients receiving immunotherapy
(Medical University of Vienna) In a study recently published in the leading journal " Blood " , researchers at MedUni Vienna provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment. The main finding is that, during the course of treatment, approximately 13% of patients develop a venous thromboembolism, that is to say a deep vein thrombosis or pulmonary embolism, and approximately 2% develop a thrombosis in the arterial system. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 31, 2021 Category: Cancer & Oncology Source Type: news

Imbio nets FDA nod for RV/LV Analysis AI algorithm
Artificial intelligence (AI) software developer Imbio has garnered U.S. Foo...Read more on AuntMinnie.comRelated Reading: Aidoc and Imbio team up on AI for pulmonary embolism New AI lab at UMass focuses on thoracic imaging Siemens adds Imbio AI apps to syngo.via platform Imbio teams up with Genentech for AI in lung disease Imbio adds analysis software to Nuance AI marketplace (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 16, 2021 Category: Radiology Source Type: news

Imbio Receives FDA 510(k) Clearance for New Cardiothoracic Imaging Algorithm
MINNEAPOLIS, March 16, 2021 -- (Healthcare Sales & Marketing Network) -- Imbio, a leading provider of artificial intelligence (AI) solutions for medical imaging analysis, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RV/LV ... Devices, Cardiology, Radiology, FDA Imbio, RV/LV Analysis, pulmonary embolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 16, 2021 Category: Pharmaceuticals Source Type: news

Why Countries Around the World Are Suspending Use of AstraZeneca ’s COVID-19 Vaccine
It’s the last thing public health officials want to see in the midst of a pandemic: more than two months after pharmaceutical giant AstraZeneca and Oxford University scientists released their COVID-19 vaccine, countries in Europe and elsewhere are pausing its use amid disconcerting reports that a small number of recipients have experienced blood clots, some of them fatal. The European Medicines Agency, which oversees drugs and vaccines in Europe, is expected to issue a guidance on March 18 about whether the side effects were related to the vaccine after reviewing the reports; in the meantime, it says the benefits of ...
Source: TIME: Health - March 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Covid-19 vaccine safe, based on scientific evidence, AstraZeneca reassures the world
It further said that, a review of available safety data of more than 17 million people vaccinated in the European Union (EU) and UK with its vaccine has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 15, 2021 Category: Pharmaceuticals Source Type: news

Blood clot in arm: Five changes to your arms that could be symptoms of a blood clot
BLOOD clots are serious medical emergencies, and could lead to a dangerous pulmonary embolism if left untreated. But how are you supposed to know if you're at risk of a blood clot in your arm? These are the five symptoms in your arm to look out for, including subtle changes to the skin. (Source: Daily Express - Health)
Source: Daily Express - Health - March 12, 2021 Category: Consumer Health News Source Type: news

AstraZeneca says 'no evidence' of higher blood clots risk from vaccine
"An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any defined age group, gender, batch or in any particular country" from the jab, a company spokesperson said. (Source: The Economic Times)
Source: The Economic Times - March 12, 2021 Category: Consumer Health News Source Type: news

Aidoc unveils AI notification application for PE
Artificial intelligence (AI) software developer Aidoc has introduced an AI-base...Read more on AuntMinnie.comRelated Reading: 3 predictions for radiology AI in 2021 Aidoc and Imbio team up on AI for pulmonary embolism FDA clears Aidoc's incidental PE AI algorithm Aidoc secures European contract FDA OKs use of Aidoc AI software for COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 2, 2021 Category: Radiology Source Type: news

Amal Mattu's Top Non-COVID Studies in 2020 Amal Mattu's Top Non-COVID Studies in 2020
Amal Mattu's picks include tips on treating gonococcal infection, the use of thrombolytics for acute ischemic stroke, and treating low-risk pulmonary embolism.Medscape Emergency Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2021 Category: Consumer Health News Tags: Emergency Medicine Viewpoint Source Type: news

Bluemke to step down as editor of Radiology
The RSNA is now accepting applications from candidates interested in becomin...Read more on AuntMinnie.comRelated Reading: Dr. Mary Mahoney becomes president of RSNA board RSNA awards Margulis prize to COVID-19 paper RSNA announces pulmonary embolism challenge winners Radiology experts list COVID-19 best practices Bluemke leaves NIH to head up Radiology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 11, 2021 Category: Radiology Source Type: news

Clinical Pearl: Pulmonary Cement Embolism
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - February 1, 2021 Category: Emergency Medicine Tags: Clinical Pearl Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe CO...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
NEW BRUNSWICK, N.J., January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468 symptomatic cases of COVID-19. The Phase 3 ENSEMBLE study is designed to evaluate the efficacy and safety of the Janssen COVID-19 vaccine candidate in protecting moderate to severe COVID-19, wit...
Source: Johnson and Johnson - January 29, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Patient Care - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Administration and Leadership - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Latest News - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS: Journal of Emergency Medical Services News - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Operations - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Be Part of the Solution: Vax Up!
JEMS proudly gives two thumbs up to the Ohio Department of Public Safety, Division of EMS, which, in partnership with the Mentor Fire Department, created an outstanding “Vax Up” edition of their “Be Part of the Solution” public service announcement (PSA) series. The Division of EMS created, and is encouraging distribution, of this PSA as a resource to encourage EMS providers to receive the COVID-19 vaccine, to highlight the importance of vaccination to all public safety personnel and to the community, and to encourage the populations in the upcoming phases of the vaccination plan to be immunized ...
Source: JEMS Special Topics - January 14, 2021 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT-P Tags: Commentary Coronavirus Spotlight EMS EMT Medicine Paramedic Source Type: news

Bilateral Pulmonary Embolism While Receiving Tranexamic Acid Bilateral Pulmonary Embolism While Receiving Tranexamic Acid
This case of bilateral pulmonary embolism in a healthy, active middle-aged woman reinforces the possible increased risk of thromboembolism in patients receiving tranexamic acid.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Screen COPD Patients With Worsening Lung Function for Pulmonary Embolism? Screen COPD Patients With Worsening Lung Function for Pulmonary Embolism?
About 6% of patients with chronic obstructive pulmonary disease who are admitted to the hospital with worsening respiratory symptoms will have pulmonary embolism, new research from France suggests.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 6, 2021 Category: Intensive Care Tags: Pulmonary Medicine News Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Patient Care - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Administration and Leadership - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Latest News - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS: Journal of Emergency Medical Services News - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Operations - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Approaches in Prehospital Sepsis Screening
Discussion In the United States, sepsis is one of the leading causes of death, which requires timely identification and proper treatment (CDC, 2019; Guerra et al., 2020; Polito et al., 2015). Based upon a review of literature conducted from 2014 to 2018, the primary investigators could locate five prehospital EMS screening tools to assist EMS providers in identifying at-risk sepsis patients. The researchers explored how the modified SIRS and qSOFA scoring systems were used in hospital settings in addition to these five prehospital EMS screening tools. The Bas 90-30-90, Guerra, PRESEP, PRESS, and Robson tools have ove...
Source: JEMS Special Topics - January 5, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Exclusives Patient Care EMS EMT Paramedic Prehospital Sepsis Source Type: news

Assessment of neutrophil extracellular traps in coronary thrombus of case series of patients with COVID-19
(JAMA Network) Severe COVID-19 is characterized by the intense formation of neutrophil extracellular traps (NETs), leading to the blockage of microvessels, as shown in pulmonary samples. The occurrence of ST-elevated myocardial infarction (STEMI) is a serious cardiac manifestation of COVID-19; the intrinsic mechanism of coronary thrombosis appears to still be unknown. This case series report of five patients sought to   determine the role of NETs in coronary thrombosis in patients with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 29, 2020 Category: Infectious Diseases Source Type: news

RSNA says 29K attended 2020 virtual meeting
Over 29,000 radiology professionals from 134 countries around the world attended...Read more on AuntMinnie.comRelated Reading: RSNA 2020 wrap-up: Missing the RSNA traditions Does RSNA 2020 measure up for vendors? RSNA awards Margulis prize to COVID-19 paper RSNA announces pulmonary embolism challenge winners How to work the virtual RSNA conference (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 15, 2020 Category: Radiology Source Type: news

Aidoc and Imbio team up on AI for pulmonary embolism
Artificial intelligence (AI) software developers Aidoc and Imbio have formed...Read more on AuntMinnie.comRelated Reading: New AI lab at UMass focuses on thoracic imaging Siemens adds Imbio AI apps to syngo.via platform FDA clears Aidoc's incidental PE AI algorithm Imbio teams up with Genentech for AI in lung disease Aidoc secures European contract FDA OKs use of Aidoc AI software for COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 8, 2020 Category: Radiology Source Type: news

RSNA awards Margulis prize to COVID-19 paper
The RSNA has awarded its Alexander R. Margulis Award for Scientific Excellence...Read more on AuntMinnie.comRelated Reading: RSNA announces pulmonary embolism challenge winners RSNA names PE as 2020 AI challenge topic RSNA unveils plans for virtual technical exhibition RSNA addresses COVID-19 impact on private practice RSNA wins grant to develop learning center in Africa (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 29, 2020 Category: Radiology Source Type: news

RSNA announces pulmonary embolism challenge winners
RSNA in collaboration with the Society for Thoracic Radiology (STR) has announced...Read more on AuntMinnie.comRelated Reading: COVID-19, AI, and dose reduction top RSNA's CT agenda How to work the virtual RSNA conference AI shows growing maturity in RSNA informatics sessions RSNA names PE as 2020 AI challenge topic ACR to develop COVID-19 imaging research registry (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 23, 2020 Category: Radiology Source Type: news

Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 20, 2020 Category: Cancer & Oncology Tags: Neurology, Oncology, Pharmacy, Pulmonology, Radiology, Journal, Source Type: news

Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism
ALAMEDA, Calif., Nov. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable faster clinical decision-... Devices Penumbra Inc, RapidAI, pulmonary embolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 10, 2020 Category: Pharmaceuticals Source Type: news

New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need f...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
RARITAN, N.J., November 5, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today more than 35 company-sponsored studies, including 10 oral presentations, will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually December 5-8, 2020.In multiple myeloma, highlights include Phase 1b/2 results for the B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR-T) therapy ciltacabtagene autoleucel (cilta-cel); new and updated data for the anti-CD38 monoclonal antibody DARZALEX® (daratumumab) and the subcutane...
Source: Johnson and Johnson - November 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Clots in COVID-19 Tied to Illness Severity, Not Virus Itself Clots in COVID-19 Tied to Illness Severity, Not Virus Itself
COVID-19 does not independently increase the risk of pulmonary embolism (PE), new findings suggest.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 5, 2020 Category: Intensive Care Tags: Cardiology News Source Type: news

Majority Of Hospitalized Coronavirus Patients Left With Heart Abnormalities, Study Finds
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4821234","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 26, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Syndicated CBSN Boston Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news

Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revasculariz...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

DVT Screening, Early Treatment, Prevent PE in Necrotizing Pancreatitis DVT Screening, Early Treatment, Prevent PE in Necrotizing Pancreatitis
Ultrasound screening enabled identification and early treatment of extremity deep vein thrombosis (DVT), thereby preventing symptomatic pulmonary embolism (PE) in a single center trial.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - October 23, 2020 Category: Gastroenterology Tags: General Surgery News Source Type: news

Imaging analysis AI startups announce 510(k)s for prostate cancer, incidental pulmonary embolism algorithms
Quantib and Ezra's automated tools support diagnosis and measurement of the prostate and prostate lesions, while Aidoc's algorithm acts as an always-on catch net for unsuspected blockage of pulmonary arteries. (Source: mobihealthnews)
Source: mobihealthnews - October 21, 2020 Category: Information Technology Source Type: news

The Most Important Things To Know About Blood Clots
Blood clots are responsible for one in four deaths globally if you include heart attacks and strokes, but people working from home may be at higher risk for pulmonary embolism too. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 14, 2020 Category: Pharmaceuticals Authors: Tara Haelle, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma Source Type: news

Pulmonary artery thrombosis a complication of radiation therapy
(American Roentgen Ray Society) According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize. Due to the differences in clinical prognosis and subsequent management strategies, in situ PAT associated with RT -- which has not previously been described in the English literature -- must be distinguished from pulmonary embolism. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 9, 2020 Category: Cancer & Oncology Source Type: news

When Loved One Is in ICU, Spouse Sees Health Risks
Compared to others, those with a spouse in the ICU had increased odds of an event such as chest pain, heart attack, stroke, irregular heart rhythm, heart failure or a blood clot in the lungs (pulmonary embolism) within a month. (Source: WebMD Health)
Source: WebMD Health - October 5, 2020 Category: Consumer Health News Source Type: news

HOME-PE Trial Clarifies Which PE Patients to Treat at Home HOME-PE Trial Clarifies Which PE Patients to Treat at Home
The randomized HOME-PE trial clarifies a transatlantic controversy regarding how best to triage patients with acute pulmonary embolism for outpatient care. Hestia criteria proved as safe as sPESI score.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 1, 2020 Category: Internal Medicine Tags: Cardiology News Source Type: news

Hospitalized COVID-19 Patients and Venous Thromboembolism Hospitalized COVID-19 Patients and Venous Thromboembolism
Early reports indicate that a very high proportion of critically ill patients hospitalized with COVID-19 will experience venous thromboembolism, particularly pulmonary embolism.Circulation (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 28, 2020 Category: Radiology Tags: Infectious Diseases Journal Article Source Type: news

Finer Risk Stratification Key in Acute Pulmonary Embolism Finer Risk Stratification Key in Acute Pulmonary Embolism
Patients with intermediate- to low-risk PE, and those with low-risk PE, require anticoagulation only. In contrast, patients with intermediate- to high-risk PE are at increased risk of decompensation.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - August 19, 2020 Category: Internal Medicine Tags: Hospital Medicine News Source Type: news

Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis
In this study, we used three thrombotic mice models to confirm the antithrombotic property of embelin. By combining the anti-inflammatory and the antithrombotic properties, we proposed embelin as a potent therapeutic agent for sepsis-induced DIC, which involves both inflammation and thrombosis. In a lipopolysaccharides-induced septic mice model, embelin not only significantly ameliorated the inflammation levels, but also effectively reduced the pulmonary hemorrhages and the micro-thrombi formations in lung. In contrast, low-molecular-weight-heparin, an anticoagulant, only moderately ameliorated the pulmonary hemorrhages an...
Source: Current Awareness Service for Health (CASH) - August 5, 2020 Category: Consumer Health News Source Type: news